AVIDBIOTICS

avidbiotics-logo

AvidBiotics is a biotherapeutics company deploying a proprietary biotechnology-derived technology platform that has multiple applications in life sciences. The company develops novel, non-antibody proteins used to target bacteria, virus-infected cells, and cancers. Its portfolio of therapeutic protein candidates and protein engineering platforms specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity systems and focuses on human therapeutic applications of its technologies that enable physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.

#People #Website #More

AVIDBIOTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2004-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.avidbiotics.com

Total Employee:
11+

Status:
Active

Contact:
6508731010

Email Addresses:
[email protected]

Total Funding:
3.69 M USD

Technology used in webpage:
U.S. Server Location


Current Employees Featured

not_available_image

Jeffery Miller
Jeffery Miller Co-Founder @ AvidBiotics
Co-Founder

david-martin_image

David Martin
David Martin CEO @ AvidBiotics
CEO
2005-01-01

Founder


david-martin_image

David Martin

not_available_image

Jeffery Miller

jim-knighton_image

Jim Knighton

Official Site Inspections

http://www.avidbiotics.com

  • Host name: ec2-13-223-25-84.compute-1.amazonaws.com
  • IP address: 13.223.25.84
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "AvidBiotics"

Avidbiotics Corp. Company Profile | South San Francisco, CA ...

Find company research, competitor information, contact details & financial data for Avidbiotics Corp. of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»

AvidBiotics Splits into Two Biotechnology Companies Each โ€ฆ

Nov 1, 2017 SOUTH SAN FRANCISCO, Calif., Nov. 1, 2017 /PRNewswire/ -- AvidBiotics, a privately held biotechnology company, today announced that its stockholders and Board of โ€ฆSee details»

AvidBiotics 2025 Company Profile: Valuation, Funding ... - PitchBook

AvidBiotics General Information Description. Developer of novel non-antibody proteins designed to target bacteria virus-infected cells and cancers. The company generates non-antibody โ€ฆSee details»

AvidBiotics - Products, Competitors, Financials, Employees ...

AvidBiotics focuses on human therapeutic applications of its technologies, both on its own and in partnership with governmental agencies and research institutions, while taking advantage of โ€ฆSee details»

Bay Areaโ€™s AvidBiotics Splits Into Two Biotech Companies

Nov 1, 2017 โ€œAs an investor in AvidBIotics we believe this action will help unlock the value and accelerate the development of these two platforms,โ€ said Kevin Cameron, independent board โ€ฆSee details»

AvidBiotics - Tech Stack, Apps, Patents & Trademarks - Crunchbase

AvidBiotics is a biotherapeutics company deploying a biotechnology-derived technology platform with multiple apps in life sciences. ... Experience the new Crunchbase, powered by AI . โ€ฆSee details»

AVIDBIOTICS CORPORATION - VentureRadar

Find out more about AVIDBIOTICS CORPORATION, Biotech, Biotechnology and Biologics. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) Funding Deals Hub; โ€ฆSee details»

Avidbiotics Corp - Company Profile and News - Bloomberg Markets

Company profile page for Avidbiotics Corp including stock price, company news, executives, board members, and contact informationSee details»

AvidBiotics Corp. - Drug pipelines, Patents, Clinical trials - Synapse

Explore AvidBiotics Corp. with its drug pipeline, therapeutic area, technology platform, 3 news, and 11 literature.See details»

AvidBiotics - Overview, News & Similar companies - ZoomInfo

Apr 14, 2020 Who is AvidBiotics. AvidBiotics has developed a portfolio of therapeutic proteins designed to selectively destroy target cells with laser precision, including cancer c ells, virus โ€ฆSee details»

AvidBiotics Corp. (AvidBiotics Corp.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ่ฏ•้ชŒ_ๆŠ• โ€ฆ

The core technology has direct applicability to human therapeutics and diagnostics, veterinary medicine and agriculture, and research tools and reagents. AvidBiotics is headquartered in โ€ฆSee details»

AvidBiotics split forms CAR-T and antibiotic specialists

Nov 1, 2017 AvidBiotics split forms CAR-T and antibiotic specialists By Phil Taylor Nov 1, 2017 10:33am antibiotic-resistant bacteria CAR-T immuno-oncology microbiomeSee details»

AvidBiotics - Contacts, Employees, Board Members, Advisors

AvidBiotics is a biotherapeutics company deploying a biotechnology-derived technology platform with multiple apps in life sciences. ... Experience the new Crunchbase, powered by AI . โ€ฆSee details»

AvidBiotics Corp | UCLA TDG

AvidBiotics generates non-antibody proteins that specifically target bacteria, viruses or cancer cells for human therapeutic and prophylactic uses, as well as food safety, biodefense, animal โ€ฆSee details»

AvidBiotics - Funding, Financials, Valuation & Investors - Crunchbase

Organization. AvidBiotics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Funding Rounds 3. obfuscated. Total Funding Amount . Unlock for โ€ฆSee details»

AvidBiotics Corp. | SBIR.gov

DESCRIPTION (provided by applicant): Acinetobacter baumannii (A. baumannii) is a human pathogen responsible for recent increases in nosocomial infections of both military and civilian โ€ฆSee details»

AVIDBIOTICS CORP South San Francisco CA, 94080 - Company โ€ฆ

Avidbiotics Corp. VISIT WEBSITE. Contact Information. 100 Kimball Way. South San Francisco, CA 94080-6218 VIEW MAP (650) 243-2951 www.avidbiotics.com Company Details. Location โ€ฆSee details»

Two New Grants for Targeted Antibacterial Proteins

South San Francisco, CA: AvidBiotics today announced the receipt of two new grants totaling $1 million dollars from the National Institutes of Health that further the development of the โ€ฆSee details»

AvidBiotics split creates two biotechs in hot areas

Nov 2, 2017 Dive Insight: This is a tale of two halves โ€” both in different, but equally hot spaces. The CAR-T field has had its ups and downs of late. Last month, following a patient death, the โ€ฆSee details»